期刊文献+

三参舒心汤治疗冠心病不稳定性心绞痛40例临床观察 被引量:9

Clinical Study on the Treatment of Unstable Angina Pectoris of Coronary Heart Disease With Sanshenshuxin Decoction
下载PDF
导出
摘要 目的:观察三参舒心汤治疗冠心病不稳定性心绞痛临床疗效及对C反应蛋白的影响。方法:随机将90例冠心病不稳定性心绞痛患者分为治疗组和对照组。对照组采用常规西药治疗,治疗组在西药治疗基础上予以三参舒心汤口服。观察两组治疗后心绞痛、心电图和中医证侯疗效及C反应蛋白水平。结果:治疗组在心绞痛和中医证侯疗效方面,及改善C反应蛋白水平方面均明显优于对照组(P<0.05或P<0.01),心电图疗效和对照组差异无统计学意义(P>0.05)。结论:三参舒心汤配合常规西药治疗冠心病不稳定心绞疗效显著,并可以有效改善治疗后C反应蛋白水平,这可能是其疗效机理之一。 Objective: To observe the effects of Sanshenshuxin decoction on unstable angina pectoris of coronary heart disease and the influence of that on C reaction protein. Methods : Ninety patients were randomly divided into treatment group and control group, the patients in control group were treated with common western medicine, the one in treatment group were treated with Sanshenshuxin decoction on the basis of therapy of control group, after treatment, the symptom of angina pectoris, electrocardiogram, therapeutic effect of TCM and the level of C reaction protein. Results : The treatment group was better than control group in the symptom of angina pectoris, therapeutic effect of TCM and the level of C reaction protein, without difference in electrocardiogram between of two groups. Conclusion. Sanshenshuxin decoction has distinct effect, can improve the level of C reaction protein effectively, that may be the one of treatment mechanisms.
出处 《中医药导报》 2008年第1期27-29,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 湖南省自然基金资助项目(NO.05JJ40025)
关键词 冠心病不稳定心绞痛 益气养阴活血法 三参舒心汤 Unstable angina pectoris of coronary heart disease Supplementing qi, nourishing yin and promoting blood flow Sanshenshuxin decoction
  • 相关文献

参考文献7

  • 1Pearson TA,Blair SN,Daniels SR,et a1.American Heart Association guide lines for primary prevention of cardiovascular disease and stroke:2002 update:consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherescleretic vascular diseases.American Heart Association Science Advisory and Coordinating Committee[J].Circulation,2002,106(3):388.
  • 2张嘉莹,朱中玉,李牧蔚,陈岩,王现青.青年急性心肌梗死患者脂蛋白(a)水平的变化及其意义[J].临床心血管病杂志,2002,18(10):500-502. 被引量:248
  • 3中华人民共和国卫生部.中药新药临床研究指导原则[s].北京:人民卫生出版社,1993.28~30.
  • 4刘德桓,许真真,郭伟聪.冠心病心绞痛395例中医证型特点探讨[J].中医杂志,1995,36(10):617-618. 被引量:95
  • 5何海英.冠心病患者C-反应蛋白的临床检测意义[J].中国综合临床,2006,22(2):116-117. 被引量:4
  • 6Yeh ET,Willerson JT.Coming of age of C reactive protein:using inflammation markersin cardiology[J].Circulation,2003,107(3):370.
  • 7Liuzzo G,Biasucci LM,Gallimore JR,et a1 The prognostic value of C rea ctive protein and serum amyloid a protein in severe unstable angina[J].N Engl J Med,1994,331(7):417.

二级参考文献12

  • 1Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease:application to clinical and public health practice:a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J].Circulation,2003,107 (3):499 -511.
  • 2Pearson TA,Blair SN,Daniels SR,et al.American Heart Association guidelines for primary prevention of cardiovascular disease and stroke:2002 update:consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases.American Heart Association Science Advisory and Coordinating Committee[J].Circulation,2002,106 (3):388-391.
  • 3Hatanaka K,Li XA,Masnda K,et al.Immunohistochemical localization of C-reactive protein binding sites in human aortic lesions by a modified streptavidin biotinstaining method[J].Pathol Int,1995,45(7):631-641.
  • 4Rebuzzi AG,Quarante L,Liuzzo G,et al.Incremental prognostic value of serum levels of tropinin T and C-reactive protein on admission in parients with unstable angina pectoris[J].Am J Cardiol,1998,82(5):715-719.
  • 5Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384.
  • 6Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046.
  • 7Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118.
  • 8Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111.
  • 9Angles C E. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997,30(11):1271-1280.
  • 10Maeda S, Abe A, Seishima M, et al. Transient change of serum lipoprotein (a) as an acute phase protein. Atherosclerosis, 1989,78(1):145-150.

共引文献860

同被引文献119

引证文献9

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部